TAUNS Laboratories, Inc.JP:197A
| Jun 30,
2022 | Jun 30,
2023 | Jun 30,
2024 |
|---|
| Profit (loss) before income taxes | 7,976 | 4,655 | 7,835 |
|---|
| Depreciation | 567 | 640 | 676 |
|---|
| Increase (decrease) in refund liability | -124 | 259 | -43 |
|---|
| Increase (decrease) in provision for bonuses | 119 | -33 | 319 |
|---|
| Increase (decrease) in provision for bonuses for directors (and other officers) | 8 | 20 | - |
|---|
| Increase (decrease) in provision for retirement benefits | 21 | 27 | 27 |
|---|
| Interest and dividend income | -2 | -7 | -8 |
|---|
| Subsidy income | -27 | - | -54 |
|---|
| Interest expenses | 8 | 22 | 31 |
|---|
| Loss (gain) on valuation of investment securities | 17 | 298 | 2 |
|---|
| Loss on valuation of shares of subsidiaries and associates | 110 | - | - |
|---|
| Loss on bonds of subsidiaries and associates | 30 | - | - |
|---|
| Loss on investments in other securities of subsidiaries and associates | 26 | - | - |
|---|
| Loss (gain) on extinguishment of tie-in shares | 3,049 | - | - |
|---|
| Loss (gain) on sale of non-current assets | 0 | -0 | -0 |
|---|
| Loss on retirement of non-current assets | 3 | 1 | 6 |
|---|
| Decrease (increase) in trade receivables | 499 | -2,109 | 344 |
|---|
| Decrease (increase) in inventories | -2,376 | 1 | -131 |
|---|
| Increase (decrease) in trade payables | 603 | -247 | 339 |
|---|
| Increase (decrease) in accrued consumption taxes | 945 | -945 | 388 |
|---|
| Other, net | 74 | -237 | 552 |
|---|
| Subtotal | 11,527 | 2,343 | 10,360 |
|---|
| Interest and dividends received | 2 | 4 | 5 |
|---|
| Interest paid | -8 | -22 | -29 |
|---|
| Subsidies received | 27 | - | 54 |
|---|
| Income taxes paid | -852 | -5,483 | -455 |
|---|
| Net cash provided by (used in) operating activities | 10,695 | -3,158 | 9,935 |
|---|
| Purchase of property, plant and equipment | -2,265 | -1,089 | -3,752 |
|---|
| Proceeds from sale of property, plant and equipment | 0 | 1 | 2 |
|---|
| Payments for retirement of property, plant and equipment | - | -0 | -1 |
|---|
| Purchase of intangible assets | -35 | -76 | -208 |
|---|
| Purchase of investment securities | -381 | -151 | -1 |
|---|
| Purchase of shares of subsidiaries and associates | - | -300 | -150 |
|---|
| Proceeds from collection of short-term loans receivable | 1 | - | - |
|---|
| Net cash provided by (used in) investing activities | -2,680 | -1,615 | -4,110 |
|---|
| Net increase (decrease) in short-term borrowings | - | 2,300 | 1,000 |
|---|
| Proceeds from long-term borrowings | 3,700 | - | 2,699 |
|---|
| Repayments of long-term borrowings | -5,560 | -732 | -732 |
|---|
| Proceeds from issuance of share acquisition rights | - | 2 | - |
|---|
| Dividends paid | -1,800 | -1,900 | -600 |
|---|
| Net cash provided by (used in) financing activities | -3,660 | -330 | 2,356 |
|---|
| Net increase (decrease) in cash and cash equivalents | 4,355 | -5,103 | 8,181 |
|---|
| Increase in cash and cash equivalents resulting from merger | 1,984 | - | - |
|---|